Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Derivados del Flúor (DDF) is a leading global manufacturer of hydrofluoric acid and a wide range of inorganic fluorides, headquartered in Spain. As a key subsidiary of the Minersa Group, the company serves as a critical supplier to the pharmaceutical and life sciences industries, providing high-purity fluorinated intermediates used in the synthesis of various active pharmaceutical ingredients (APIs). DDF operates advanced manufacturing facilities that adhere to international quality standards, ensuring the supply of essential chemical building blocks for drug development and production. Their expertise in fluorine chemistry allows them to support complex chemical processes across the healthcare, electronics, and industrial sectors. The company is recognized for its large-scale production capacity and its strategic role in the global fluorine chemical supply chain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Derivados del Flúor.